Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 18 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases